# Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/elranatamab-in-relapsed-or-refractory-multiple-myeloma-phase-2-magnetismm-3/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alexander M. Lesokhin,Michael H. Tomasson,Bertrand Arnulf,Nizar J. Bahlis,H. Miles Prince,Rubén Niesvizky,Paula Rodríguez‐Otero,Joaquín Martínez‐López,Guenther Koehne,Cyrille Touzeau,Yogesh Jethava,Hang Quach,Julien Depaus,Hisayuki Yokoyama,Afshin Eli Gabayan,Don A. Stevens,Ajay K. Nooka,Salomon Manier,Noopur Raje,Shinsuke Iida,Marc S. Raab,Emma Searle,Eric Leip,Sharon T. Sullivan,Umberto Conte,Mohamed Elmeliegy,Akos Czibere,Andrea Viqueira,Mohamad Mohty |
| Citations | 592 |
| DOI | 10.1038/s41591-023-02528-9 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41591-023-02528-9.pdf |
| OpenAlex ID | https://openalex.org/W4385839624 |
| PMID | 37582952 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Paula Rodríguez‐Otero](https://scholariq.org/researchers/paula-rodriguez-otero/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.